98 results found.

Adult Primary Hepatocellular Carcinoma, Localized Unresectable Ad Clinical Trial using sorafenib tosylate; placebo; doxorubicin hydrochloride; doxorubicin-eluting beads; cisplatin; mitomycin C

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase III Randomized, Double-Blind Trial of Chemoembolization With or Without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients With and Without Vascular Invasion.
sorafenib tosylate; placebo; doxorubicin hydrochloride; doxorubicin-eluting beads; cisplatin; mitomycin C

Colorectal Cancer Metastatic Clinical Trial using TheraSphere

BTG International Inc. - Recruiting 18 years or older.
- A Phase III Clinical Trial Evaluating TheraSpherer in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy.
TheraSphere

Liver Cancer Clinical Trial using yttrium Y 90 glass microspheres; Cisplatin; Mitomycin; Doxorubicin

Northwestern University - Recruiting 18 years or older.
- An Investigator Initiated Multicenter Prospective Randomized Study of Chemoembolization Versus Radioembolization for the Treatment of Hepatocellular Carcinoma (PREMIERE Trial).
yttrium Y 90 glass microspheres; Cisplatin; Mitomycin; Doxorubicin

Hepatic Complications, Liver Metastases, or Unspecified Adult Sol Clinical Trial using trametinib; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I Trial of Single Agent Trametinib (GSK1120212) in Advanced Cancer Patients With Hepatic Dysfunction.
trametinib; pharmacological study; laboratory biomarker analysis

Carcinoma, Hepatocellular Clinical Trial using Everolimus; Tacrolimus; Myfortic; CellCept

Baylor Research Institute - Recruiting 18 years or older.
- A 36 Month Multi-center, Open Label, Randomized, Comparator Study to Evaluate the Efficacy and Safety of Everolimus Immunosuppression Treatment in Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria.
Everolimus; Tacrolimus; Myfortic; CellCept

Rectal Cancer Clinical Trial using folfox; short course Radiotherapy

Yonsei University - Recruiting 18 years or older.
- A Phase 2 Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis.
folfox; short course Radiotherapy

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Clinical Trial using oxaliplatin; irinotecan hydrochloride; leucovorin calcium; fluorouracil; laboratory biomarker analysis

University of Chicago - Recruiting 18 years or older.
- A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies.
oxaliplatin; irinotecan hydrochloride; leucovorin calcium; fluorouracil; laboratory biomarker analysis

Colon Cancer, Rectum Cancer, or Liver Metastases Clinical Trial using Lap+Lus

Odense University Hospital - Recruiting 18 years or older.
- The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum: A Prospective Randomized Trial.
Lap+Lus

Metastatic Colorectal Cancer Clinical Trial using FOLFOXIRI + Cetuximab; FOLFOXIRI

Sun Yat-sen University - Recruiting 18 years to 75 years.
- A Phase II Study to Evaluate the Surgical Conversion Rate in Patients Receiving FOLFOXIRI +/- Cetuximab for Unresectable Wild-Type KRAS/NRAS Colorectal Cancer With Metastases Confined to the Liver.
FOLFOXIRI + Cetuximab; FOLFOXIRI

Cancer Metastatic to the Liver, Hepatocellular Carcinoma That is Clinical Trial using PV-10 (10% rose bengal disodium)

Provectus Pharmaceuticals - Recruiting 18 years or older.
- A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma Not Amenable to Resection or Transplant.
PV-10 (10% rose bengal disodium)

Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Can Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites..

Liver Diseases, Hepatocellular Cancer, Endstage Liver Disease, or Clinical Trial using donor pain management/ Pre-operative OR Set-up

Northwestern University - Recruiting 21 years to 60 years.
- A2ALL-Patients Safety System Improvements in Living Donor Liver Transplant.
donor pain management/ Pre-operative OR Set-up

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using yttrium Y 90 glass microspheres; laboratory biomarker analysis

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Humanitarian Device Exemption Treatment Protocol of TheraSpherer For Treatment of Unresectable Hepatocellular Carcinoma.
yttrium Y 90 glass microspheres; laboratory biomarker analysis

Advanced Cancers Clinical Trial using Oxaliplatin; Capecitabine; Bevacizumab

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Phase I Clinical Trial of Hepatic Arterial Infusion of Oxaliplatin, Oral Capecitabine, With or Without Systemic Bevacizumab for Patients With Advanced Cancer Metastatic to the Liver.
Oxaliplatin; Capecitabine; Bevacizumab

Adult Primary Hepatocellular Carcinoma, Adult Primary Undifferent Clinical Trial using sorafenib tosylate; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting N/A or older.
- Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC.
sorafenib tosylate; laboratory biomarker analysis

Adult Acute Lymphoblastic Leukemia in Remission, Adult Nasal Type Clinical Trial using dasatinib; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517; IND-73969) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction.
dasatinib; pharmacological study

Liver Cancer, Neoplasms, Liver, or Hepatic Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Prospective Pilot Observational Study Examining Cone Beam CT and CT Thermometry During Ablations.

Colorectal Cancer, Liver Metastasis, or Colorectal Adenocarcinoma Clinical Trial using Sulindac; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer.
Sulindac; Placebo

Liver Cell Caricinoma, Liver Cancer, or Hepatocellular Carcinoma Clinical Trial using Tremelimumab; Trans-Arterial Cather Chemoembolization; Radiofrequency Ablation (RFA)

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Pilot Study of Tremelimumab, A Monoclonal Antibody Against CTLA-4, in Combination With Either Trans-Arterial Catheter Chemoembolization (TACE) or Radiofrequency Ablation (RFA) in Subjects With Hepatocellular Carcinoma (HCC).
Tremelimumab; Trans-Arterial Cather Chemoembolization; Radiofrequency Ablation (RFA)

Lung Neoplasms, Liver Neoplasms, Kidney Neoplasms, or Cancer Clinical Trial using Laser-Assisted Angle Selection System; Block-Assisted Angle Selection System

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy.
Laser-Assisted Angle Selection System; Block-Assisted Angle Selection System

Carcinoma, Hepatocellular, Liver Cirrhosis, Alcoholic, Hepatitis, Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area.

Liver Metastases, Stage IVA Colon Cancer, Stage IVB Colon Cancer, Clinical Trial using dynamic contrast-enhanced ultrasound imaging

Stanford University - Recruiting 18 years or older.
- Pilot Feasibility Study on 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Patients With Liver Metastases.
dynamic contrast-enhanced ultrasound imaging

Colorectal Neoplasms Clinical Trial using Regorafenib (Stivarga, BAY73-4506); Placebo

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled Phase-III Study of Adjuvant Regorafenib Versus Placebo for Patients With Stage IV Colorectal Cancer After Curative Treatment of Liver Metastases.
Regorafenib (Stivarga, BAY73-4506); Placebo

Hepatocellular Carcinoma Clinical Trial using Vitamin B-6; Coenzyme Q10; Vitamin B-6+Coenzyme Q10; Placebo

Taichung Veterans General Hospital - Recruiting 20 years to 80 years.
- .
Vitamin B-6; Coenzyme Q10; Vitamin B-6+Coenzyme Q10; Placebo

Liver Cancer, or Pancreatic Cancer Clinical Trial using Intravenous Patient-Controlled Analgesia (IVPCA); Thoracic Epidural Analgesia (TEA); Questionnaires; Pain Assessment

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient Controlled Analgesia (3:1) in Patients Undergoing Liver and/or Pancreatic Resection.
Intravenous Patient-Controlled Analgesia (IVPCA); Thoracic Epidural Analgesia (TEA); Questionnaires; Pain Assessment

Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis Clinical Trial using TheraSphere; Sorafenib

BTG International Inc. - Recruiting 18 years or older.
- A Prospective Randomized Clinical Trial on 90Yttrium Trans-arterial Radio-Embolization (TheraSpherer) vs. Standard of Care (Sorafenib) for the Treatment of Advanced Hepatocellular Carcinoma (HCC) With Portal Vein Thrombosis (PVT).
TheraSphere; Sorafenib

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using tivozanib; pharmacological study; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Multicenter Phase 1b/2 Study of Tivozanib in Patients With Advanced Inoperable Hepatocellular Carcinoma.
tivozanib; pharmacological study; laboratory biomarker analysis

Liver Cancer, or Metastatic Cancer Clinical Trial using capecitabine; yttrium Y 90 glass microspheres

Northwestern University - Recruiting 18 years or older.
- Dose Escalating Study of Yttrium 90 Microspheres (TheraSphere) With Capecitabine (Xeloda) for Intrahepatic Cholangiocarcinoma or Metastatic Disease to the Liver.
capecitabine; yttrium Y 90 glass microspheres

Hepatoma, Liver Neoplasms, Adenoma, Liver Cell, or Carcinoma, Hep Clinical Trial using TRC 105; Sorafenib

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase I/II Study of TRC105 in Combination With Sorafenib in Hepatocellular Carcinoma (HCC).
TRC 105; Sorafenib

Unresectable Hepatocellular Carcinoma Clinical Trial using TheraSphere

BTG International Inc. - Recruiting 18 years or older.
- A Phase III Clinical Trial of Intra-arterial TheraSpherer in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC).
TheraSphere

Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Bod Clinical Trial using ipilimumab; yttrium Y 90 glass microspheres; laboratory biomarker analysis

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver.
ipilimumab; yttrium Y 90 glass microspheres; laboratory biomarker analysis

Metastatic Hepatocellular Carcinoma, or Advanced Liver Cancer Clinical Trial using Ascorbic Acid + Sorafenib; Sorafenib alone

Thomas Jefferson University - Recruiting 18 years or older.
- Phase I/II Study of Intravenous Ascorbic Acid in Treatment of Metastatic Hepatocellular Carcinoma.
Ascorbic Acid + Sorafenib; Sorafenib alone

Colorectal Cancer, Neoplasm Metastasis Clinical Trial using bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- A Multi-center, Single-arm, Pilot Study of 5-FU Based Doublet Chemotherapy Plus Bevacizumab as Neoadjuvant Therapy for Patients With Previously Untreated Unresectable Liver-only Metastases From Colorectal Cancer.
bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Locally Advanced Tumor, Metastatic Solid Tissue Tumors, Liver Can Clinical Trial using DCVax-Direct

Northwest Biotherapeutics - Recruiting 18 years to 75 years.
- A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS.
DCVax-Direct

Adult Primary Liver Cancer, or Kidney Tumor Clinical Trial using ultrasound elasticity imaging

Stanford University - Recruiting 19 years or older.
- US Elastography for Characterizing Focal Lesions in the Liver and Kidney.
ultrasound elasticity imaging

Colorectal Cancer Metastatic, Liver Metastases, or KRAS Wild Type Clinical Trial using FOLFOX6; Bevacizumab; Panitumumab; Surgery

European Organisation for Research and Treatment of Cancer - EORTC - Recruiting 18 years to 75 years.
- Randomized Phase II Trial Evaluating the Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab as Perioperative Treatment in Patients With Resectable Liver Metastases From Wild Type KRAS Colorectal Cancer.
FOLFOX6; Bevacizumab; Panitumumab; Surgery

Cancer Liver, Cancer Brain, Cancer Head &Neck, or Cancer Pelvis Clinical Trial using MRI Group

University of Michigan Cancer Center - Recruiting 18 years or older.
- Optimization of MRI for Radiation Therapy.
MRI Group

Cancer of Kidney and Renal Pelvis, or Cancer of Liver Clinical Trial using Dexmedetomidine

Uppsala University Hospital - Recruiting 18 years to 80 years.
- Effects of Dexmedetomidine on Periprocedural Pain During Radiofrequency Ablation of Liver and Kidney Tumours.
Dexmedetomidine

Cryptogenic Pyogenic Liver Abscess Clinical Trial

Inje University - Recruiting 18 years or older.
- The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess.

Cancer of Liver, or Cancer of Pancreas Clinical Trial using Dexmedetomidine

Uppsala University Hospital - Recruiting 18 years to 85 years.
- Effects of Dexmedetomidine on Anaesthesia During IRE Procedures for Solid Tumours.
Dexmedetomidine

Colorectal Cancer Clinical Trial using bevacizumab [Avastin]; mFOLFOX6

Hoffmann-La Roche - Recruiting 18 years or older.
- A Multi-center, Open-label Clinical Trial to Evaluate the Objective Response Rate of Bevacizumab in Combination With Modified FOLFOX-6 Followed by One Year of Maintenance With Bevacizumab Alone in Patients With Initially Not or Borderline Resectable Colorectal Liver Metastases (The CLMO-001 Trial).
bevacizumab [Avastin]; mFOLFOX6

Liver Cancer Clinical Trial using onartuzumab; sorafenib

Hoffmann-La Roche - Recruiting 18 years or older.
- A PHASE Ib, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ONARTUZUMAB GIVEN AS A SINGLE AGENT AND IN COMBINATION WITH SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC).
onartuzumab; sorafenib

Hepatectomy, Elective Hepatectomy, or Malignant Tumors Clinical Trial using Oral immunonutrition; Placebo

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Interest of Preoperative Immunonutrition in Liver Resection for Cancer.
Oral immunonutrition; Placebo

Hepatic Complications, Renal Failure, or Unspecified Adult Solid Clinical Trial using dabrafenib; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 1 and Pharmacokinetic Study of Dabrafenib (GSK2118436B) in Patients With BRAFV600X Mutations and Renal or Hepatic Dysfunction.
dabrafenib; pharmacological study; laboratory biomarker analysis

Hepatocellular Carcinoma, Hepatocellular Cancer, or Carcinoma, He Clinical Trial using TRC105

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 80 years.
- A Phase II Study of TRC105 in Patients With Hepatocellular Carcinoma (HCC) Who Have Progressed on Sorafenib.
TRC105

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Clinical Trial using romidepsin; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia and Select Solid Tumors and Varying Degrees of Liver Dysfunction.
romidepsin; pharmacological study

Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Clinical Trial using 6,8-bis(benzylthio)octanoic acid

Comprehensive Cancer Center of Wake Forest University - Recruiting 18 years or older.
- A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers.
6,8-bis(benzylthio)octanoic acid

Carcinoma, Hepatocellular Clinical Trial using PF-03446962; Best Supportive Care; Best supportive care

Pfizer - Recruiting 18 years or older.
- A Phase 2, Randomized, Open Label Study To Evaluate The Efficacy, Safety, Pharmacodynamics, Pharmacokinetics Of The Anti-ALK-1 MAB PF-03446962 In Combination With Best Supportive Care VS. Best Supportive Care Alone In Adult Patients With Advanced Hepatocellular Carcinoma.
PF-03446962; Best Supportive Care; Best supportive care

Hepatitis, HIV, or Liver Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- The Natural History of Liver Disease in a Cohort of Participants With Hepatitis B and/or Hepatitis C With or Without HIV Infection.

Liver Neoplasms, Hepatic Cancer, or Liver Cancer Clinical Trial using Thermal Ablation; Standard External Beam Radiation Therapy

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 64 years.
- Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms.
Thermal Ablation; Standard External Beam Radiation Therapy

Liver Cancer Clinical Trial using doxorubicin-eluting beads; everolimus; placebo

Swiss Group for Clinical Cancer Research - Recruiting 18 years or older.
- A Phase I Open Label/Phase II Randomized, Double-Blind, Multicenter Trial Investigating the Combination of Everolimus and TransArterial ChemoEmbolization (TACE) With Doxorubicin in Patients With Hepatocellular Carcinoma.
doxorubicin-eluting beads; everolimus; placebo

Colorectal Cancer Clinical Trial using Cetuximab; Bevacizumab; Irinotecan; Oxaliplatin; 5-FU; Folinic Acid

Technische Universit„t Dresden - Recruiting 18 years or older.
- Open, Randomized, Multicenter Phase II Trial With Cetuximab /5-FU/FA/Irinotecan or Cetuximab/5-FU/FA /Irinotecan/Oxaliplatin in K-ras/B-raf Wild Type Patients or With Irinotecan/Oxaliplatin/5-FU/FA With or Without Bevacizumab in K-ras Mutant Patients as Neoadjuvant Treatment in Patients With Non- Resectable Colorectal Liver Metastases..
Cetuximab; Bevacizumab; Irinotecan; Oxaliplatin; 5-FU; Folinic Acid

Cancer, Metastases, or Liver Neoplasms Clinical Trial using Liver MRI with Gdfos; Liver MRI with EcGd

Sunnybrook Health Sciences Centre - Recruiting 18 years or older.
- Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial.
Liver MRI with Gdfos; Liver MRI with EcGd

Liver Cancer, or Advanced Cancer Clinical Trial using Irinotecan; Bevacizumab; Oxaliplatin; Cetuximab

M.D. Anderson Cancer Center - Recruiting N/A or older.
- A Multi-arm Phase I Trial of Hepatic Arterial Infusion of Irinotecan With 1) Systemic Bevacizumab 2) Systemic Bevacizumab and Oxaliplatin 3) Systemic Bevacizumab and Cetuximab in Patients With Advanced Cancers Metastatic to the Liver.
Irinotecan; Bevacizumab; Oxaliplatin; Cetuximab

Esophageal Cancer, or Esophageal Stenosis Clinical Trial using Partially covered SEMS; Fully covered SEMS

Foundation for Liver Research - Recruiting 18 years or older.
- A Randomized Comparison of a Fully Covered Self Expandable Metal Stent Versus a Partially Covered Self Expandable Metal Stent in Malignant Esophageal Strictures.
Partially covered SEMS; Fully covered SEMS

Liver Cancer Clinical Trial using ARQ197; Placebo

Kyowa Hakko Kirin Company, Limited - Recruiting 20 years or older.
- A Phase III Randomized Double-blind, Placebo-controlled Trial of ARQ 197 in Subjects With c-MET Diagnostic-high Inoperable Hepatocellular Carcinoma (HCC) Treated With One Prior Sorafenib Therapy.
ARQ197; Placebo

Advanced Hepatocellular Carcinoma, HCC, or Liver Cancer Clinical Trial using PD-0332991

Thomas Jefferson University - Recruiting 18 years or older.
- A Phase II Study of PD-0332991 in Adult Patients With Advanced Hepatocellular Carcinoma.
PD-0332991

Liver Cancer Clinical Trial using Lenalidomide

National Taiwan University Hospital - Recruiting 20 years or older.
- Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma (HCC): a Phase II Clinical Trial.
Lenalidomide

Advanced Adult Hepatocellular Carcinoma Clinical Trial using Best Supportive Care; sorafenib

National Cancer Institute, Naples - Recruiting 18 years or older.
- Sorafenib in the First Line Treatment of Advanced Hepatocellular Carcinoma With Child-Pugh Liver Function Class B: Multicentre Phase 3 Randomized Trial.
Best Supportive Care; sorafenib

Pancreatic Cancer Clinical Trial using Neoadjuvant chemoradiation; Upfront surgery

Seoul National University Hospital - Recruiting 18 years to 75 years.
- Multicenter Prospective Randomized Phase II/III Study of Neoadjuvant Chemoradiation With Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer.
Neoadjuvant chemoradiation; Upfront surgery

Liver Cancer Clinical Trial using Sorafenib; Yttrium-90 Microspheres; Follow-Up Phone Calls

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma, BCLC Stage C.
Sorafenib; Yttrium-90 Microspheres; Follow-Up Phone Calls

Colorectal Cancer, or Metastatic Cancer Clinical Trial using floxuridine; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II Multi-Institutional Efficacy and Safety Study of Chemotherapy With Selective Internal Radiation Treatment Using Y-90 Microspheres (CHEMO-SIRT) in Patients With Colorectal Cancer Liver Metastasis.
floxuridine; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

Metastatic Breast Cancer, Lung Metastases, or Liver Metastases Clinical Trial using anti-OX40 antibody

Providence Health & Services - Recruiting 18 years or older.
- Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy..
anti-OX40 antibody

Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Pre Clinical Trial using sorafenib tosylate; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 2 years to 30 years.
- A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma.
sorafenib tosylate; pharmacological study; laboratory biomarker analysis

Hepatocellular Carcinoma Clinical Trial using Drug-Eluting Beads (DEB) with Doxorubicin; Lipiodol Ethanol Mixture (LEM)

Masonic Cancer Center, University of Minnesota - Recruiting 18 years or older.
- Prospective Study Comparing Lipiodol Plus Ethanol Solution Compared With Drug-Eluting Beads for Trans-arterial Chemoembolization of Liver in Treatment of Hepatocellular Carcinoma.
Drug-Eluting Beads (DEB) with Doxorubicin; Lipiodol Ethanol Mixture (LEM)

Cancer of the Liver, Liver Cancer, Hepatoma, Liver Neoplasms, or Clinical Trial using Salmonella typhimurium

Masonic Cancer Center, University of Minnesota - Recruiting 18 years or older.
- A Phase 1 Study of an IL-2 Expressing, Attenuated Salmonella Typhimurium in Patients With Unresectable Hepatic Spread From Any Non-Hematologic Primary.
Salmonella typhimurium

Colorectal Cancer Clinical Trial using two stage hepatectomy

Centre Hospitalier Universitaire, Amiens - Recruiting 18 years or older.
- Associating Liver Partition and Portal Vein Ligation (ALPPS) for Potentially Resectable Liver Metastasis From Colorectal Cancer: Prospective Evaluation of the Early Two-stage Hepatectomy by the Simon's Methods.
two stage hepatectomy

Liver Cancer Clinical Trial using bevacizumab; erlotinib hydrochloride; sorafenib tosylate

Medical University of South Carolina - Recruiting 18 years or older.
- A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC).
bevacizumab; erlotinib hydrochloride; sorafenib tosylate

Liver Cancer Clinical Trial using yttrium Y 90 glass microspheres

Northwestern University - Recruiting 18 years or older.
- A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma.
yttrium Y 90 glass microspheres

Liver Cancer, or Metastatic Cancer Clinical Trial using Yttrium Y 90 glass microspheres

Northwestern University - Recruiting 18 years or older.
- A Humanitarian Device Exemption Compassionate Use Protocol of TheraSphere for Treatment of Unresectable Metastatic Cancer to the Liver.
Yttrium Y 90 glass microspheres

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using stereotactic body radiation therapy

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- A Pilot Study of Stereotactic Liver Irradiation for Hepatocellular Carcinoma.
stereotactic body radiation therapy

Lung Cancer, or Liver Cancer Clinical Trial

National Taiwan University Hospital - Recruiting 20 years to 90 years.
- The Study of the Knowledge, Attitudes, and Decision Making Towards Clinical Trials in Cancer Patients.

Liver Cancer Clinical Trial using Fluoromethylcholine (FCH) PET/CT Imaging

Queen's Medical Centre - Recruiting 18 years or older.
- Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer.
Fluoromethylcholine (FCH) PET/CT Imaging

Nausea, Vomiting, or Metastatic Liver Cancer Clinical Trial using acupoint electric stimulation; tropisetron

Fudan University - Recruiting 18 years or older.
- Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE.
acupoint electric stimulation; tropisetron

Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage I Clinical Trial using therapeutic conventional surgery; cisplatin; fluorouracil; vincristine sulfate; doxorubicin hydrochloride; irinotecan hydrochloride; liver transplantation; laboratory biomarker analysis

Children's Oncology Group - Recruiting N/A to 21 years.
- Treatment of Children With All Stages of Hepatoblastoma.
therapeutic conventional surgery; cisplatin; fluorouracil; vincristine sulfate; doxorubicin hydrochloride; irinotecan hydrochloride; liver transplantation; laboratory biomarker analysis

Colorectal and Ovarian Cancer Patients With Liver Metastasis Clinical Trial using EMD525797

Merck KGaA - Recruiting 18 years or older.
- A Phase I, Open-label, Dose-escalation Study to Investigate the Safety, Tolerability, PD and PK of EMD 525797 Using DCE-MRI as a PK Measure of Response in Colorectal and Ovarian Cancer Patients With Liver Metastases After Failure of Standard Therapy.
EMD525797

Liver Cancer Clinical Trial using Electrosensing antibody probing system (e- Ab sensor)

National Taiwan University Hospital - Recruiting 20 years to 75 years.
- Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor).
Electrosensing antibody probing system (e- Ab sensor)

Cancer of Liver Clinical Trial using radiofrequency ablation associated with TACE; radiofrequency ablation only

Southwest Hospital, China - Recruiting 18 years to 75 years.
- Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation Associated With Postoperative Transhepatic Arterial Chemoembolization--a Prospective Randomized Clinical Trial.
radiofrequency ablation associated with TACE; radiofrequency ablation only

Colorectal Neoplasms, Neoplasm Metastasis, or Liver Neoplasms Clinical Trial using Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Fudan University - Recruiting 18 years to 75 years.
- Study of Cetuximab in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer.
Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Hepatocellular Carcinoma, or Liver Cancer Clinical Trial using Microwave Ablation

St. Joseph Hospital of Orange - Recruiting 18 years or older.
- Microwave Ablation of Resectable Liver Tumors.
Microwave Ablation

Rectal Cancer, or Liver Metastases Clinical Trial using Capecitabine, Oxaliplatin; Radiotherapy

Asan Medical Center - Recruiting 20 years to 75 years.
- Randomized Phase II Trial of Preoperative Chemoradiation With or Without Induction Chemotherapy In Patients With Locally Advanced Or Borderlinely Resectable Rectal Cancer With Resectable Synchronous Liver Metastases.
Capecitabine, Oxaliplatin; Radiotherapy

Metastatic Colorectal Cancer Clinical Trial using Perfusion CT scan

University of Oxford - Recruiting 18 years or older.
- Perfusion Computed Tomography Pilot Study in the NCRN FOXFIRE Clinical Trial to Determine Blood Flow to Liver Metastases.
Perfusion CT scan

Colorectal Cancer With Liver Metastasis Clinical Trial using perihepatic lymphadenectomy

Gachon University Gil Medical Center - Recruiting 18 years to 80 years.
- Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis.
perihepatic lymphadenectomy

Liver Tumors Clinical Trial using Stereotactic Body Radiation Therapy

AHS Cancer Control Alberta - Recruiting 18 years or older.
- A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors.
Stereotactic Body Radiation Therapy

Hepatocellular Carcinoma Clinical Trial using LC Bead loaded with doxorubicin

University of Pittsburgh - Recruiting 18 years or older.
- LC Drug Eluting Bead for Regional Chemoembolization to Downstage Unresectable Hepatocellular Carcinoma (HCC) to Liver Transplantation.
LC Bead loaded with doxorubicin

Extrahepatic Bile Duct Cancer, Gallbladder Cancer, or Liver Cance Clinical Trial using cisplatin; fluorouracil; gemcitabine hydrochloride; oxaliplatin

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Randomized Phase II-III Study of Chemoradiation With Fluorouracil and Cisplatin Versus Chemotherapy (Gemcitabine/Oxaliplatin) in Non Resectable But Non Metastatic Cancer of the Biliary Tract.
cisplatin; fluorouracil; gemcitabine hydrochloride; oxaliplatin

Cervical Cancer, Hpv, or Warts Clinical Trial using Quadrivalent HPV for types 6, 11, 16 and 18

Medstar Research Institute - Recruiting 9 years to 17 years.
- Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients..
Quadrivalent HPV for types 6, 11, 16 and 18

Liver Cancer Clinical Trial using nutritional support before operation

Peking Union Medical College Hospital - Recruiting 18 years to 90 years.
- A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support.
nutritional support before operation

Hepatocellular Carcinoma, Liver Cirrhosis, Hepatitis B, or Hepati Clinical Trial using CE-US (SonazoidT); B-mode US

Japan Liver Oncology Group - Recruiting 20 years or older.
- Sonazoid Enhanced Liver Cancer Trial for Early Detection.
CE-US (SonazoidT); B-mode US

Liver Cancer Clinical Trial

National Taiwan University Hospital - Recruiting N/A or older.
- Sharable Knowledge Mining Platform for Clinical Data Extraction, and Medical Knowledge and Mining Services Sharing.

Carcinoma, Hepatocellular Clinical Trial using Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Pegylated Interferon Embolization (TAIE)

Hospital Authority, Hong Kong - Recruiting 18 years or older.
- A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Hepatocellular Carcinoma.
Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Pegylated Interferon Embolization (TAIE)

Hepatitis B Clinical Trial using Educational Small Group Session; Educational small group session

University of California, Los Angeles - Recruiting 18 years to 64 years.
- Increasing Hepatitis B Screening Among Korean Church Attendees (Component Project) Program Project Title: Liver Cancer Control Interventions for Asian Americans.
Educational Small Group Session; Educational small group session

Hepatocellular Carcinoma, or Liver Cancer Clinical Trial using Radiofrequency ablation; TACE

Sun Yat-sen University - Recruiting 18 years to 75 years.
- Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
Radiofrequency ablation; TACE

Hepatocellular Carcinoma Clinical Trial using sirolimus

Fudan University - Recruiting 18 years to 75 years.
- A Prospective Randomised, Open-Labeled Study Comparing Sirolimus Versus FK506 In OLT for Patients With HCC Exceeding Milan Criteria.
sirolimus

Hepatocellular Carcinoma Clinical Trial using Thymopentin

Fudan University - Recruiting 18 years to 75 years.
- Phase III Study of Thymopentin in Patients After Curative Resection of Small.
Thymopentin

Colorectal Cancer, Liver Neoplasms, Hepatocellular Carcinoma, Gal Clinical Trial using interventionally implanted hepatic arterial port catheter

Charite University, Berlin, Germany - Recruiting 18 years or older.
- Open One-Arm Therapy Optimizing Trial on Regional Chemotherapy of the Liver Through an Interventionally Implanted A.Hepatica Port System in Patients With Liver Metastases or Primary Liver Neoplasms..
interventionally implanted hepatic arterial port catheter

Hepatocellular Carcinoma Clinical Trial

National Taiwan University Hospital - Recruiting 18 years to 90 years.
- Identification of Differentially Expressed Genes in Hepatocellular Carcinoma With DNA Microarrays.